DK172037B1 - Monoklonale antistoffer med cyclosporiner, hybridomcellelinje og immunoassaykit eller -system - Google Patents

Monoklonale antistoffer med cyclosporiner, hybridomcellelinje og immunoassaykit eller -system Download PDF

Info

Publication number
DK172037B1
DK172037B1 DK261386A DK261386A DK172037B1 DK 172037 B1 DK172037 B1 DK 172037B1 DK 261386 A DK261386 A DK 261386A DK 261386 A DK261386 A DK 261386A DK 172037 B1 DK172037 B1 DK 172037B1
Authority
DK
Denmark
Prior art keywords
cyclosporin
monoclonal antibody
group
cyclosporins
residue
Prior art date
Application number
DK261386A
Other languages
Danish (da)
English (en)
Other versions
DK261386A (da
DK261386D0 (da
Inventor
Joachim Rosenthaler
Roland Wenger
Philipp E Ball
Max H Schreier
Valerie Quesniaux
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB848425040A external-priority patent/GB8425040D0/en
Priority claimed from GB858515673A external-priority patent/GB8515673D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of DK261386A publication Critical patent/DK261386A/da
Publication of DK261386D0 publication Critical patent/DK261386D0/da
Application granted granted Critical
Publication of DK172037B1 publication Critical patent/DK172037B1/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64Cyclic peptides containing only normal peptide links
    • C07K7/645Cyclosporins; Related peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Cephalosporin Compounds (AREA)
DK261386A 1984-10-04 1986-06-03 Monoklonale antistoffer med cyclosporiner, hybridomcellelinje og immunoassaykit eller -system DK172037B1 (da)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB848425040A GB8425040D0 (en) 1984-10-04 1984-10-04 Organic compounds
GB8425040 1984-10-04
GB8515673 1985-06-20
GB858515673A GB8515673D0 (en) 1985-06-20 1985-06-20 Organic compounds
EP8500501 1985-09-27
PCT/EP1985/000501 WO1986002080A1 (en) 1984-10-04 1985-09-27 Monoclonal antibodies to cyclosporings

Publications (3)

Publication Number Publication Date
DK261386A DK261386A (da) 1986-06-03
DK261386D0 DK261386D0 (da) 1986-06-03
DK172037B1 true DK172037B1 (da) 1997-09-22

Family

ID=26288301

Family Applications (1)

Application Number Title Priority Date Filing Date
DK261386A DK172037B1 (da) 1984-10-04 1986-06-03 Monoklonale antistoffer med cyclosporiner, hybridomcellelinje og immunoassaykit eller -system

Country Status (15)

Country Link
EP (4) EP0314861A1 (ja)
JP (1) JPH074269B2 (ja)
KR (1) KR910002691B1 (ja)
AT (1) ATE92501T1 (ja)
AU (4) AU589917B2 (ja)
CA (1) CA1309671C (ja)
CY (2) CY1915A (ja)
DE (2) DE3587505T2 (ja)
DK (1) DK172037B1 (ja)
ES (1) ES8702949A1 (ja)
FI (1) FI93965C (ja)
HK (2) HK78696A (ja)
NO (1) NO173557C (ja)
NZ (1) NZ213680A (ja)
WO (1) WO1986002080A1 (ja)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5427960A (en) * 1987-03-27 1995-06-27 Abbott Laboratories Fluorescence polarization assay for cyclosporin A and metabolites and related immunogens and antibodies
EP0283801A3 (en) * 1987-03-27 1990-05-30 Abbott Laboratories Fluorescence polarization assay for cyclosporin a and metabolites and related immunogens and antibodies
US5239057A (en) * 1987-03-27 1993-08-24 Abbott Laboratories Fluorescence polarization assay for cyclosporin a and metabolites and related immunogens and antibodies
US5698448A (en) * 1988-12-02 1997-12-16 Soldin; Steven J. Immunosuppressive drug binding proteins and use
AU4958590A (en) * 1988-12-05 1990-07-10 Trustees Of Columbia University In The City Of New York, The Novel derivatives of cyclosporine a, antibodies directed thereto and uses thereof
GB8916901D0 (en) 1989-07-24 1989-09-06 Sandoz Ltd Improvements in or relating to organic compounds
EP0473961B1 (en) * 1990-08-15 1996-01-03 Abbott Laboratories Immunoassay reagents and method for determining cyclosporine
CA2048302A1 (en) * 1990-08-15 1992-02-16 Victoria P. Meucci Solubilization reagent for biological test samples
DE69133095T2 (de) * 1990-11-20 2003-03-27 Dade Behring Marburg Gmbh Cyclosporin-Immunoassay
GB9307491D0 (en) 1993-04-08 1993-06-02 Sandoz Ltd Organic compounds
USRE40596E1 (en) * 1993-04-08 2008-12-02 Novartis Ag Rapamycin assay
US6270957B1 (en) 1997-08-26 2001-08-07 Wisconsin Alumni Research Foundation Non-Imuunosuppressive cyclosporins and their use in the prevention and treatment of HIV infection
WO1999010374A1 (en) * 1997-08-26 1999-03-04 Wisconsin Alumni Research Foundation Cyclosporin a conjugates and uses therefor
US5990274A (en) 1997-11-25 1999-11-23 Dade Behring Inc. Cyclosporine derivatives and uses thereof
EP1091975B1 (fr) 1998-07-01 2005-12-14 Debiopharm S.A. Nouvelle cyclosporine ayant un profil d'activite ameliore
WO2000022000A1 (en) * 1998-10-09 2000-04-20 Isotechnika, Inc. Methods for the production of antibodies to specific regions of cyclosporine and cyclosporine metabolites
US6686454B1 (en) 1998-10-09 2004-02-03 Isotechnika, Inc. Antibodies to specific regions of cyclosporine related compounds
ES2326040T3 (es) 2001-10-19 2009-09-29 Isotechnika Inc. Sintesis de analogos de ciclosporina.
WO2008147982A1 (en) 2007-05-24 2008-12-04 Abbott Laboratories Immunoassays exhibiting reduced cross-reactivity with hydrophobic drug analyte metabolites
TW200932240A (en) 2007-10-25 2009-08-01 Astellas Pharma Inc Pharmaceutical composition containing lipophilic substance which inhibits IL-2 production
KR101659457B1 (ko) * 2008-05-23 2016-09-23 더 유니버시티 오브 브리티쉬 콜롬비아 리포좀 나노입자에 사용하기 위한 변형된 약물
WO2010088573A1 (en) 2009-01-30 2010-08-05 Enanta Pharmaceuticals, Inc. Cyclosporin analogues for preventing or treating hepatitis c infection
US8481483B2 (en) 2009-02-19 2013-07-09 Enanta Pharmaceuticals, Inc. Cyclosporin analogues
US8685917B2 (en) 2009-07-09 2014-04-01 Enanta Pharmaceuticals, Inc. Cyclosporin analogues
US8367053B2 (en) 2009-07-09 2013-02-05 Enanta Pharmaceuticals, Inc. Cyclosporin analogues
US8349312B2 (en) 2009-07-09 2013-01-08 Enanta Pharmaceuticals, Inc. Proline substituted cyclosporin analogues
US8623814B2 (en) 2010-02-23 2014-01-07 Enanta Pharmaceuticals, Inc. Antiviral agents
US9428845B1 (en) 2010-12-28 2016-08-30 Warp Drive Bio, Inc. Identifying new therapeutic agents
WO2012145427A1 (en) 2011-04-18 2012-10-26 The Trustees Of Columbia University In The City Of New York Methods to treat cancer using cyclosporine and cyclosporine derivatives
WO2014085623A1 (en) 2012-11-28 2014-06-05 Enanta Pharmaceuticals, Inc. Novel [n-me-4-hydroxyleucine]-9-cyclosporin analogues
JP2016538317A (ja) 2013-08-26 2016-12-08 エナンタ ファーマシューティカルズ インコーポレイテッド C型肝炎を防止または治療するための新規シクロスポリン類似体
WO2016073480A1 (en) 2014-11-03 2016-05-12 Enanta Pharmaceuticals, Inc. Novel cyclosporin analogues for preventing or treating hepatitis c infection
EP4289950A3 (en) 2015-01-09 2024-01-24 Revolution Medicines, Inc. Macrocyclic compounds that participate in cooperative binding and medical uses thereof
AU2016329064B2 (en) * 2015-10-01 2023-10-19 Warp Drive Bio, Inc. Methods and reagents for analyzing protein-protein interfaces
EP3442599B1 (en) 2016-04-12 2022-03-30 Warp Drive Bio, Inc. Compositions and methods for the production of compounds
US11479797B2 (en) 2016-10-28 2022-10-25 Ginkgo Bioworks, Inc. Compositions and methods for the production of compounds
CA3159561A1 (en) 2019-11-04 2021-05-14 Revolution Medicines, Inc. Ras inhibitors
WO2021091967A1 (en) 2019-11-04 2021-05-14 Revolution Medicines, Inc. Ras inhibitors
JP2022553859A (ja) 2019-11-04 2022-12-26 レボリューション メディシンズ インコーポレイテッド Ras阻害剤
CA3194067A1 (en) 2020-09-15 2022-03-24 Revolution Medicines, Inc. Ras inhibitors

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB211526A (en) 1922-09-22 1924-02-22 John Fletcher Holliday Improvements in and relating to chain grate stokers
CH614931A5 (ja) * 1975-11-04 1979-12-28 Sandoz Ag
US4210581A (en) 1975-11-04 1980-07-01 Sandoz Ltd. Organic compounds
DE2819094A1 (de) 1977-05-10 1978-11-23 Sandoz Ag Cyclosporin-derivate, ihre verwendung und herstellung
DE3167014D1 (en) 1980-02-14 1984-12-13 Sandoz Ag A method for the total synthesis of cyclosporins and novel cyclosporins
IL62965A0 (en) 1980-07-17 1981-07-31 Scripps Miles Lab Inc Monoclonal antibodies to drugs and theri production
DE3260468D1 (en) * 1981-01-09 1984-09-06 Sandoz Ag Novel cyclosporins
CH667274A5 (de) 1984-03-23 1988-09-30 Sandoz Ag Cyclosporine, ihre herstellung und diese enthaltende pharmazeutische zusammensetzungen.
GB8407618D0 (en) 1984-03-23 1984-05-02 Sandoz Ltd Organic compounds

Also Published As

Publication number Publication date
ES8702949A1 (es) 1987-01-16
DE3587342T2 (de) 1993-12-02
EP0290762B1 (en) 1993-05-12
EP0290762A1 (en) 1988-11-17
FI862370A0 (fi) 1986-06-03
HK78696A (en) 1996-05-10
FI862370A (fi) 1986-06-03
EP0198026B1 (en) 1993-08-04
DK261386A (da) 1986-06-03
EP0314862A1 (en) 1989-05-10
HK124696A (en) 1996-07-19
EP0314861A1 (en) 1989-05-10
NZ213680A (en) 1990-05-28
AU589917B2 (en) 1989-10-26
JPS62500383A (ja) 1987-02-19
NO173557C (no) 1993-12-29
AU3914289A (en) 1989-10-26
DE3587505D1 (de) 1993-09-09
KR870700637A (ko) 1987-12-30
NO173557B (no) 1993-09-20
DE3587505T2 (de) 1994-01-05
CY1915A (en) 1985-09-27
ES547495A0 (es) 1987-01-16
NO862177D0 (no) 1986-06-02
JPH074269B2 (ja) 1995-01-25
EP0198026A1 (en) 1986-10-22
NO862177L (no) 1986-08-04
ATE92501T1 (de) 1993-08-15
KR910002691B1 (ko) 1991-05-03
CY1927A (en) 1997-05-16
CA1309671C (en) 1992-11-03
WO1986002080A1 (en) 1986-04-10
AU3914189A (en) 1989-11-16
AU3914389A (en) 1989-11-16
DK261386D0 (da) 1986-06-03
DE3587342D1 (en) 1993-06-17
AU4967185A (en) 1986-04-17
FI93965B (fi) 1995-03-15
FI93965C (fi) 1995-06-26

Similar Documents

Publication Publication Date Title
DK172037B1 (da) Monoklonale antistoffer med cyclosporiner, hybridomcellelinje og immunoassaykit eller -system
US5169773A (en) Monoclonal antibodies to cyclosporins
US6541612B2 (en) Monoclonal antibodies obtained using rapamycin position 27 conjugates as an immunogen
US8030458B2 (en) Monoclonal antibodies to tacrolimus and immunoassays methods for tacrolimus
JP4896959B2 (ja) ドキソルビシン免疫測定法
AU2013305884A1 (en) Antibodies to risperidone haptens and use thereof
AU2013305938A1 (en) Antibodies to paliperidone haptens and use thereof
JP2005508877A (ja) イムノアッセイにおいて有用なプロテアーゼインヒビターコンジュゲートおよび抗体
JP3714942B2 (ja) 生物体液中のバンコマイシンの検出および定量化用試薬および方法
JP3595506B2 (ja) シクロスポリンおよびシクロスポリン代謝産物の、特定領域に対する抗体の生産方法
EP1498415B1 (en) Ecstasy-class derivatives, immunogens, and antibodies and their use in detecting ecstasy-class drugs
CA1338653C (en) Labeled derivatives of cyclosporins
EP0742903B1 (en) Piperidine analogs and conjugates of procainamide and napa
JPH08511164A (ja) ブレキナールおよび類縁体の検出のためのイムノアッセイ試剤および方法

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired